Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 4, 2000, Pages 1001-1006

  Gaspar, Laurie E ^a   Scott, Charles ^b   Murray, Kevin ^c   Curran, Walter ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b RTOG Headquarters   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Brain metastases; Prognostic factors; Radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIOSURGERY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME;

AGE FACTORS; AGED; BRAIN NEOPLASMS; DOSE FRACTIONATION; HUMANS; KARNOFSKY PERFORMANCE STATUS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS;

EID: 0034237213     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00547-2     Document Type: Article

References (24)

1. Gaspar L.E., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 37:1997;745-751.
2. Murray K.J., Scott C., Greenberg H.M., et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastasis A report of the Radiation Therapy Oncology Group (RTOG) 9104 . Int J Radiat Oncol Biol Phys. 39:1997;571-574.
3. Gordon L., Olshen R.A. Tree-structured survival analysis. Cancer Treat Rep. 69:1985;1065-1069.
4. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
5. Peto R., Pike M.C., Amritage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part 2. Analysis and examples. Br J Cancer. 35:1977;1-39.
6. Prentice R.L., Marek P. A qualified discrepancy between censored data rank tests. Biometrics. 35:1979;861-867.
7. Hommel G. A stagewise rejective multiple test procedure based on a modified Boferroni test. Biometrika. 75:1988;383-386.
8. Hommel G. A comparison of two modified Bonferroni procedures. Biometrika. 76:1989;624-625.
9. Komarnicky L.T., Phillips T.L., Martz K., et al. A randomized Phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-79-16). Int J Radiat Oncol Biol Phys. 20:1991;53-58.
10. Phillips T.L., Scott C.B., Leibel S., et al. Results of a randomized comparison of radiotherapy and bromodeoxyuridine to radiotherapy alone for brain metastases Report of RTOG trial 89-05 . Int J Radiat Oncol Biol Phys. 30:1994;215.
11. Sause W.T., Scott C., Krisch R., et al. Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28. Int J Radiat Oncol Biol Phys. 26:1993;653-657.
12. Brookmeyer R., Crowley J.A. Confidence interval for the median survival time. Biometrics. 38:1982;29-41.
13. Adler J.R., Cox R.S., Kaplan I., et al. Stereotactic radiosurgical treatment of brain metastases. J Neurosurg. 76:1992;444-449.
14. Noordijk E.M., Vecht C.J., Haaxma-Reiche H., et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys. 29:1994;711-717.
15. Patchell R.A., Tibbs P.A., Walsh J.W., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 322:1990;494-500.
16. Flickinger J.C., Kondziolka D., Lunsford L.D., et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys. 28:1994;797-801.
17. Smalley S.R., Laws E.R., O'Fallon J.R., et al. Resection for solitary brain metastasis Role of adjuvant radiation and prognostic variables in 229 patients . J Neurosurg. 77:1992;531-540.
18. Joseph J., Adler J.R., Cox R.S., et al. Stereotaxic radiosurgery of brain metastases The influence of number of lesions on survival . Int J Radiat Oncol Biol Phys. 27:1993;256.
19. Fuller B.G., Kaplan I.D., Adler J., et al. Stereotaxic radiosurgery for brain metastases The importance of adjuvant whole brain irradiation . Int J Radiat Oncol Biol Phys. 23:1992;413-418.
20. Nieder C., Schwerdtfeger K., Steudel W.I., et al. Patterns of relapse and late toxicity after resection and whole-brain radiotherapy for solitary brain metastases. Strahlenther Onkol. 174:1998;275-278.
21. Agboola O., Benoit B., Cross P., et al. Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. Int J Radiat Oncol Biol Phys. 42:1998;155-159.
22. Williams J., Enger C., Wharam M., et al. Stereotactic radiosurgery for brain metastases Comparison of lung carcinoma vs. non-lung tumors . J Neurooncol. 37:1998;79-85.
23. Wronski M., Maor M.H., Davis B.J., et al. External radiation of brain metastases from renal carcinoma A retrospective study of 119 patients from the M.D. Anderson Cancer Center . Int J Radiat Oncol Biol Phys. 3:1997;753-759.
24. Seung S.K., Sneed P.K., McDermott M.W., et al. Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am. 4:1998;103-109.